Collaborations

GlobeImmune currently has collaboration agreements with:

• Celgene Corporation  for the development of GlobeImmune’s oncology Tarmogens
• Gilead Sciences, Inc. for the development of hepatitis B virus (HBV) Tarmogens

GlobeImmune plans to seek third-party collaborators for the development of certain other Tarmogen product candidates.